Tag

Weight Loss Industry

All articles tagged with #weight loss industry

business1 year ago

"Oprah Winfrey's Departure from Weight Watchers Board Sparks Stock Drop and Diet Industry Concerns"

Oprah Winfrey's decision to leave the board of WW International caused the company's stock to plummet by 25%, signaling potential challenges for the weight loss giant. The "Oprah Effect" had previously boosted WW's value, but the company now faces uncertainty in a changing diet culture and the rise of weight-loss medications. As WW seeks a new identity, its pivot to offering weight-loss drugs may shape its future in the evolving wellness industry.

business1 year ago

"Oprah Winfrey's Departure Sends Weight Watchers Stock Plummeting"

Oprah Winfrey is set to leave the board of Weight Watchers, a company struggling to compete with weight-loss drugs' popularity. She revealed using weight-loss drugs as a "maintenance tool" and plans to donate her shares to the National Museum of African American History and Culture. Weight Watchers faces a major shift in the weight-loss industry with the launch of anti-obesity drugs like Wegovy and Ozempic, and recently reported a net loss of $88.1m. The company also announced the acquisition of digital health company Sequence to incorporate prescription medications into its weight loss program.

business2 years ago

"Battle for Market Dominance: Healthcare Giants Compete in the Lucrative Weight-Loss Industry"

The weight-loss industry is projected to be worth $100 billion by 2030, attracting the interest of several major healthcare companies. Eli Lilly and Novo Nordisk are currently leading the market with their weight-loss drugs, Zepbound and Ozempic/Wegovy, respectively. Pfizer and AstraZeneca are also developing weight-loss drugs that could potentially compete in the future. AstraZeneca recently acquired a license for an anti-obesity medication, ECC5004, while Pfizer is working on a once-daily version of danuglipron. Roche is a long shot in the market, as its promising drug CT-388 is still in early-stage trials. Investors are advised to consider Eli Lilly and Novo Nordisk as the top choices for weight-loss stocks, while taking a wait-and-see approach with Pfizer, AstraZeneca, and Roche.

business2 years ago

Jenny Craig faces potential bankruptcy and office closures.

Weight loss company Jenny Craig may shut down its corporate office in California and New Jersey facility as early as Friday due to bankruptcy. The company is likely to transition to an e-commerce model. The weight loss industry is experiencing a seismic shift as drugs like Wegovy, Manjaro, and Ozempic have been shown to help people lose weight. WW, formerly known as Weight Watchers, has acquired Sequence, a subscription-based platform that provides telemedicine appointments with doctors who can prescribe Ozempic and Wegovy.